Takei Mariko, Matsuno Hiroyuki, Okada Kiyotaka, Ueshima Shigeru, Matsuo Osamu, Kozawa Osamu
Department of Pharmacology, Gifu University School of Medicine, Tsukasa-machi 40, Gifu 500, Japan.
J Thromb Thrombolysis. 2002 Dec;14(3):205-11. doi: 10.1023/a:1025096609558.
The role of alpha2-antiplasmin (alpha2-AP) on platelet aggregation was investigated using mice deficient in alpha2-AP (alpha2-AP(-/-)) or using wild type mice (alpha2-AP(+/+)).
Blood samples were taken from each mouse under anesthesia with ether and platelet rich plasma (PRP) was prepared. Platelet aggregation induced by various doses of ADP (0.3-30 microM) was detected using a laser-light scattering (LS) system. Aggregated forms were observed using a scanning electron microscopy (SEM).
Dose-dependent platelet aggregation was not different in both types of mice. However, platelet micro-aggregate formation in alpha2-AP(-/-) mice induced by low dose of ADP (1.0 microM) markedly increased compared to the situation in wild type mice. Aggregated form detected by SEM showed supported data from LS analysis. When washed platelets of alpha2-AP(+/+) mice were resuspended in plasma of alpha2-AP(-/-) mice, platelet micro-aggregation was also increased. On the contrary, when washed platelets of alpha2-AP(-/-) mice were suspended in plasma of alpha2-AP(+/+) mice, platelet micro-aggregation did not change. In separate experiments, tPA (1.0 microg/ml) was added to PRP before the stimulation of ADP. tPA had no effect on platelet aggregation in alpha2-AP(+/+) mice, however platelet micro-aggregation in alpha2-AP(-/-) mice was markedly increased by the treatment with tPA. Moreover, the amount of released ATP from stimulated platelets was increased in alpha2-AP(-/-) mice treated with tPA.
Lack of alpha2-AP increased platelet micro-aggregation, and plasmin plays an important role in the formation of platelet aggregation when alpha2-AP knockout mice are used. Consequently, the reduction of alpha2-AP could be a risk factor for the activation of platelets resulting in thrombus formation.
利用α2-抗纤溶酶(α2-AP)缺陷小鼠(α2-AP(-/-))或野生型小鼠(α2-AP(+/+))研究了α2-抗纤溶酶对血小板聚集的作用。
在乙醚麻醉下从每只小鼠采集血样并制备富含血小板血浆(PRP)。使用激光散射(LS)系统检测不同剂量ADP(0.3 - 30微摩尔)诱导的血小板聚集。使用扫描电子显微镜(SEM)观察聚集形式。
两种类型小鼠中剂量依赖性血小板聚集无差异。然而,与野生型小鼠相比,低剂量ADP(1.0微摩尔)诱导的α2-AP(-/-)小鼠血小板微聚集体形成明显增加。SEM检测到的聚集形式显示支持LS分析的数据。当α2-AP(+/+)小鼠的洗涤血小板重悬于α2-AP(-/-)小鼠的血浆中时,血小板微聚集也增加。相反,当α2-AP(-/-)小鼠的洗涤血小板悬浮于α2-AP(+/+)小鼠的血浆中时,血小板微聚集没有变化。在单独实验中,在ADP刺激前向PRP中加入组织型纤溶酶原激活剂(tPA,1.0微克/毫升)。tPA对α2-AP(+/+)小鼠的血小板聚集无影响,然而tPA处理使α2-AP(-/-)小鼠的血小板微聚集明显增加。此外,tPA处理的α2-AP(-/-)小鼠中受刺激血小板释放的ATP量增加。
α2-AP缺乏增加血小板微聚集,并且当使用α2-AP基因敲除小鼠时,纤溶酶在血小板聚集形成中起重要作用。因此,α2-AP的减少可能是导致血小板活化形成血栓的危险因素。